Kinetic Changes in Liver Parenchyma After Preoperative Chemotherapy for Patients with Colorectal Liver Metastases

[1]  M. Makuuchi,et al.  Recovery of Liver Function After the Cessation of Preoperative Chemotherapy for Colorectal Liver Metastasis , 2010, Annals of Surgical Oncology.

[2]  L. Rubbia‐Brandt,et al.  Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  S. Yoshifuku,et al.  Increasing prevalence of diabetes mellitus in association with fatty liver in a Japanese population , 2014, Journal of Gastroenterology.

[4]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[5]  D. Sargent,et al.  Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  浦田 浩一,et al.  Calculation of child and adult standard liver volume for liver transplantation , 1995 .

[7]  A. Zhu,et al.  Hepatic toxicities associated with the use of preoperative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liver. , 2009, The oncologist.

[8]  J. Vauthey,et al.  Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases. , 2009, The Lancet. Oncology.

[9]  T. Gruenberger,et al.  Evaluation of Chemotherapy-Associated Liver Injury in Patients with Colorectal Cancer Liver Metastases Using Indocyanine Green Clearance Testing , 2011, Annals of Surgical Oncology.

[10]  P. Bachellier,et al.  Liver Injury Due to Chemotherapy-induced Sinusoidal Obstruction Syndrome Is Associated with Sinusoidal Capillarization , 2012, Annals of Surgical Oncology.

[11]  N. Kokudo,et al.  Assessment of liver function for safe hepatic resection , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[12]  J. Weitz,et al.  Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. , 2010, The Lancet. Oncology.

[13]  S. Curley,et al.  Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. , 2007, Journal of the American College of Surgeons.

[14]  P. Ohman‐Strickland,et al.  Changes in liver and spleen volumes and liver function after radioembolization with yttrium-90 resin microspheres. , 2011, Journal of vascular and interventional radiology : JVIR.

[15]  H. Kijima,et al.  Evaluation of the Usefulness of the Indocyanine Green Clearance Test for Chemotherapy-Associated Liver Injury in Patients with Colorectal Cancer Liver Metastasis , 2014, Annals of surgical oncology.

[16]  C. Köhne,et al.  Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  L. Påhlman,et al.  Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. , 2015, Cancer treatment reviews.

[18]  J. Shindoh,et al.  Optimal Future Liver Remnant in Patients Treated with Extensive Preoperative Chemotherapy for Colorectal Liver Metastases , 2013, Annals of Surgical Oncology.

[19]  S. Kawasaki,et al.  Surgery for small liver cancers. , 1993, Seminars in surgical oncology.

[20]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[21]  Daniel Azoulay,et al.  Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  N. Kemeny.  Presurgical chemotherapy in patients being considered for liver resection. , 2007, The oncologist.

[23]  P. Bachellier,et al.  What Is a Safe Future Liver Remnant Size in Patients Undergoing Major Hepatectomy for Colorectal Liver Metastases and Treated by Intensive Preoperative Chemotherapy? , 2012, Annals of Surgical Oncology.

[24]  T. Pawlik,et al.  Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.